COLFAX CORP (CFX) Stock Overview
USA - NYSE:CFX - Common Stock
CFX Key Statistics, Chart & Performance
The current stock price of CFX is 39.06 null. In the past month the price increased by 7.54%. In the past year, price decreased by -10.02%.
CFX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PH | PARKER HANNIFIN CORP | 26.8 | 92.88B | ||
| ITW | ILLINOIS TOOL WORKS | 25.87 | 76.53B | ||
| OTIS | OTIS WORLDWIDE CORP | 23.16 | 35.08B | ||
| XYL | XYLEM INC | 30.91 | 34.46B | ||
| IR | INGERSOLL-RAND INC | 24.39 | 31.02B | ||
| SYM | SYMBOTIC INC | 320 | 28.34B | ||
| DOV | DOVER CORP | 19.05 | 23.41B | ||
| PNR | PENTAIR PLC | 23.36 | 17.88B | ||
| SNA | SNAP-ON INC | 17.67 | 17.28B | ||
| FTV | FORTIVE CORP | 13.46 | 16.26B | ||
| GGG | GRACO INC | 30.19 | 14.01B | ||
| ITT | ITT INC | 29.61 | 13.97B |
Related stock screener links
About CFX
Company Profile
Colfax Corp. operates as a diversified technology company. The company is headquartered in Wilmington, Delaware and currently employs 16,200 full-time employees. The company went IPO on 2008-05-08. The Company’s segments include Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. Its fabrication technology products are marketed under several brands, including ESAB. The Medical Technology segment develops, manufactures and distributes medical devices and services across the continuum of patient care from injury prevention to joint replacement to the rehabilitation after surgery, injury from degenerative disease, enabling people to regain or maintain their natural motion. Its products are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, athletic trainers and other healthcare professionals.
Company Info
COLFAX CORP
2711 Centerville Road, Suite 400
Wilmington DELAWARE 20701 US
CEO: Matthew L. Trerotola
Employees: 16200
Phone: 13022529160.0
COLFAX CORP / CFX FAQ
What is the stock price of COLFAX CORP today?
The current stock price of CFX is 39.06 null. The price decreased by -3.77% in the last trading session.
What is the ticker symbol for COLFAX CORP stock?
The exchange symbol of COLFAX CORP is CFX and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is CFX stock listed?
CFX stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for COLFAX CORP stock?
19 analysts have analysed CFX and the average price target is 51.43 null. This implies a price increase of 31.66% is expected in the next year compared to the current price of 39.06. Check the COLFAX CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is COLFAX CORP worth?
COLFAX CORP (CFX) has a market capitalization of 6.10B null. This makes CFX a Mid Cap stock.
How many employees does COLFAX CORP have?
COLFAX CORP (CFX) currently has 16200 employees.
What are the support and resistance levels for COLFAX CORP (CFX) stock?
COLFAX CORP (CFX) has a support level at 37.29 and a resistance level at 40.03. Check the full technical report for a detailed analysis of CFX support and resistance levels.
Is COLFAX CORP (CFX) expected to grow?
The Revenue of COLFAX CORP (CFX) is expected to grow by 7.2% in the next year. Check the estimates tab for more information on the CFX EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy COLFAX CORP (CFX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CFX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CFX, evaluating the profitability, health, valuation and growth aspects
- COLFAX CORP (CFX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- COLFAX CORP (CFX) Sales and EPS estimates to see what analysts future expectations are.
- COLFAX CORP (CFX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- COLFAX CORP (CFX) Insider and Institutional Ownership to learn about the owners and their transactions.
- COLFAX CORP (CFX) Stock Chart to make your own analysis
- COLFAX CORP (CFX) Latest news and press-releases to stay up to date.
Does COLFAX CORP (CFX) stock pay dividends?
CFX does not pay a dividend.
When does COLFAX CORP (CFX) report earnings?
COLFAX CORP (CFX) will report earnings on 2022-04-28, before the market open.
What is the Price/Earnings (PE) ratio of COLFAX CORP (CFX)?
The PE ratio for COLFAX CORP (CFX) is 18.34. This is based on the reported non-GAAP earnings per share of 2.13 and the current share price of 39.06 null. Check the full fundamental report for a full analysis of the valuation metrics for CFX.
CFX Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to CFX. When comparing the yearly performance of all stocks, CFX is a bad performer in the overall market: 61.5% of all stocks are doing better.
CFX Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CFX. Both the profitability and financial health of CFX have multiple concerns.
CFX Financial Highlights
Over the last trailing twelve months CFX reported a non-GAAP Earnings per Share(EPS) of 2.13. The EPS increased by 53.24% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.86% | ||
| ROA | 0.84% | ||
| ROE | 1.55% | ||
| Debt/Equity | 0.45 |
CFX Forecast & Estimates
19 analysts have analysed CFX and the average price target is 51.43 null. This implies a price increase of 31.66% is expected in the next year compared to the current price of 39.06.
For the next year, analysts expect an EPS growth of 241.51% and a revenue growth 7.2% for CFX